18223 Long-term proactive management of psoriasis vulgaris with fixed-dose combination of 0.005% calcipotriene and 0.064% betamethasone dipropionate foam: Results of a phase III randomized controlled trial

Autor: Lebwohl, Mark, Lacour, Jean-Philippe, Liljedahl, Monika, Lynde, Charles, Holst Mørch, Marie, Marieke Snel-Prentø, Anja, Thaçi, Diamant, Warren, Richard B.
Zdroj: In Journal of the American Academy of Dermatology December 2020 83(6) Supplement:AB208-AB208
Databáze: ScienceDirect